"According to Rosenberg, his team was working around the clock to streamline the process."
Washington, May 12 - In a groundbreaking treatment, researchers at the National Cancer Institute in the US have harnessed a female patient's own immune system to fight cancer.

The team sequenced the genome of her cancer and identified cells from her immune system that attacked a specific mutation in the malignant cells.

Then they grew those immune cells in the lab and infused billions of them back into her bloodstream, a report in the journal Science said.

The tumours began melting away, said Steven A. Rosenberg, chief of the surgery branch at the cancer institute.

The 43-year-old woman was diagnosed with an advanced and deadly type of cancer that had spread from her bile duct to her liver and lungs, despite chemotherapy.

The report is noteworthy because it describes an approach that may also be applied to common tumours - like those in the digestive tract, ovaries, pancreas, lungs and breasts, the report noted.

Researchers said the treatment, known as adoptive cell therapy, holds promise for common cancers. But they also cautioned that the report was early and based on just one patient.

According to Rosenberg, his team was working around the clock to streamline the process.

Potentially, if we could reduce the complexity, it's something that could get out into common usage eventually, he added.


comments powered by Disqus
Read more on:
 

PERMALINK

http://www.nerve.in/news:2535002373524
You can quote the permanent link above for a direct link to the story. We do not archive or expire our news stories.


STORY OPTIONS
  Email this story to a friend
  XML feed for Americas


 
COPYRIGHTS INFORMATION
All rights reserved for news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.
Contact Nerve Staff for any feedback, corrections and omissions in news stories.
 

All rights reserved for the news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.